Wearable optical device detects diabetic complication

Complications of diabetes are more easily treated when they are found early.  Researchers at National Taiwan University Hospital have developed a wearable optical device to detect diabetic autonomic neuropathy, a common diabetic complication, that could be better than existing detection methods.

CDC takes steps to improve lab safety after anthrax, flu scares

In response to back-to-back incidents involving government laboratories, a top official at the U.S. Centers for Disease Control and Prevention has resigned, and the agency has assembled a safety board to address concerns that have arisen after workers were potentially exposed to anthrax and H5N1 flu.

FDA final guidance modifies 510(k) rules, discourages use of multiple predicate devices

In a new final guidance issued in July, the FDA announced that it will frown upon the use of multiple predicate devices in 510(k) submissions, unlike when it cleared metal-on-metal hip implants, which the Agency later said can damage surrounding bones and contaminate the body by releasing ions into the bloodstream.

3-D printing grows to scale within industry

Over the past two decades, 3-D printing has grown from a niche technology to a multibillion-dollar industry.  The manufacturing process was developed in the 1980s as a way to produce small volumes of scale models but has since expanded to include the manufacturing of medical devices and implants for surgical and clinical use.  The process, also known as additive manufacturing, uses computer models to build three-dimensional objects by printing materials like plastic, polymers, metals and powders in layers.

Why isn’t New York City a biotech hub?

New York City is the center of the world’s largest economy, home to some banner medical institutions and a hotbed of global financiers. However, the city has never evolved into the biotech hotbed local leaders have hoped to see, a failure largely due to one of its inescapable traits:  high rent.

MedTech Prices Lag Behind CPI, Other Medical Goods

Spending on MedTech Steady at Six Percent of U.S. Health Expenditures:  Medical technology prices continue their trend of consistently low growth, increasing at approximately one-third the rate of prices in the overall economy and one-fifth the rate of prices for other medical goods and services over a 23-year period, according to an updated study released today by the Advanced Medical Technology Association (AdvaMed).